RGT 3.03% 32.0¢ argent biopharma limited

Ann: Half Yearly Report and Accounts, page-4

  1. 53 Posts.
    If you read into it more carefully you'd realise the half yearly report and accounts consist of; acquisitions and product production costs etc, which is hardly a surprise IMO.


    If I'm correct, everything on the accounts aren't surprising even the negative net profit since main cashflow for the business doesn't commence until next month!

    If anyone can give us a deeper analysis of the accounts without being bias, I'm all ears. Otherwise, I look forward to the full years report regarding sales growth which will be interesting along with further updates regarding this;



    Definitely sounds like a positive for me if they believe so.

    Regards,
    quickfix
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
-0.010(3.03%)
Mkt cap ! $15.48M
Open High Low Value Volume
34.0¢ 34.0¢ 32.0¢ $6.532K 19.88K

Buyers (Bids)

No. Vol. Price($)
1 15000 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 5000 1
View Market Depth
Last trade - 14.37pm 04/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.